UCSF is co-sponsoring a symposium on September 27 and 28 featuring speakers from academia, industry, the US Food and Drug Administration (FDA), and the California Institute for Regenerative Medicine (CIRM).
The symposium titled “Stem Cell Translation: Strategies, Best Practices & Regulatory Considerations” is designed to provide scientists and physicians with the “nuts and bolts” of translating stem cell science into cell-based products for clinical trials.
The experts will share their perspectives on various issues that define the successful application of novel stem cell-based approaches, including human subjects and ethical issues, product characterization, development and testing of cell lines, preclinical animal studies, design and manufacturing of cell products, and complying with regulatory requirements.
The symposium is slated for Monday and Tuesday, Sept. 27 and 28, from 8 a.m. to 4:30 p.m. in the UCSF Mission Bay Conference Center. Fees range from $350 to $450. Partial scholarships are available to UCSF postdocs. The application deadline is Monday, Sept. 13, 2010.